Selected article for: "atypical pneumonia and co infection"
Author: Chaudhry, Rama; Sreenath, K.; Vinayaraj, E. V.; Sahoo, Biswajeet; Vishnu Narayanan, M. R.; Kiran, K. V. P. Sai; Batra, Priyam; Rathor, Nisha; Singh, Sheetal; Mohan, Anant; Bhatnagar, Sushma
Title: Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report
  • Cord-id: rkhia6o8
  • Document date: 2021_3_10
    • ID: rkhia6o8
    Snippet: We report co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Mycoplasma pneumoniae in a patient with pneumonia in India. Atypical bacterial pathogens causing community-acquired pneumonia may share similar clinical presentations and radiographic features with SARS-CoV-2 making a thorough differential diagnosis essential. The co-infection of SARS-CoV-2 and M. pneumoniae is infrequently reported in the literature. Broader testing for common respiratory pathogens shou
    Document: We report co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Mycoplasma pneumoniae in a patient with pneumonia in India. Atypical bacterial pathogens causing community-acquired pneumonia may share similar clinical presentations and radiographic features with SARS-CoV-2 making a thorough differential diagnosis essential. The co-infection of SARS-CoV-2 and M. pneumoniae is infrequently reported in the literature. Broader testing for common respiratory pathogens should be performed in severe COVID-19 cases to rule out other concurrent infections. Early identification of co-existing respiratory pathogens could provide pathogen-directed therapy, and can save patient lives during the ongoing COVID-19 outbreak.

    Search related documents:
    Co phrase search for related documents
    • acute kidney injury and lopinavir ritonavir tocilizumab: 1, 2
    • acute pneumonia and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute pneumonia and lopinavir ritonavir tocilizumab: 1, 2
    • acute pneumonia and lopinavir ritonavir tocilizumab remdesivir: 1
    • acute pneumonia and lopinavir ritonavir tocilizumab remdesivir hydroxychloroquine: 1, 2
    • acute pneumonia and lopinavir ritonavir tocilizumab remdesivir hydroxychloroquine treatment: 1
    • acute pneumonia and lung expansion: 1, 2, 3
    • acute pneumonia ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8
    • acute pneumonia ards respiratory distress syndrome and lopinavir ritonavir tocilizumab: 1
    • acute pneumonia ards respiratory distress syndrome and lopinavir ritonavir tocilizumab remdesivir: 1
    • acute pneumonia ards respiratory distress syndrome and lopinavir ritonavir tocilizumab remdesivir hydroxychloroquine: 1
    • acute pneumonia ards respiratory distress syndrome and lopinavir ritonavir tocilizumab remdesivir hydroxychloroquine treatment: 1